#1058 Methicillin-Resistant Staphylococcus Aureus Infections (MRSA) (12 Credits/hours)

Course Details:
Launch Date: August 5, 2025
Expires: August 31, 2027

Course #1058
12 Credits/Hours

Course Overview

This comprehensive course provides healthcare professionals and students with essential knowledge about Methicillin-Resistant Staphylococcus Aureus (MRSA) infections. The course covers the microbiology, epidemiology, clinical manifestations, diagnosis, treatment, and prevention strategies for MRSA. Participants will gain practical understanding of managing MRSA infections in various healthcare settings and community environments.

Table of Contents

1. Introduction to MRSA: History, Evolution, and Significance
2. Microbiology and Mechanisms of Resistance
3. Epidemiology and Transmission Patterns
4. Clinical Manifestations and Disease Presentations
5. Diagnostic Approaches and Laboratory Testing
6. Treatment Strategies and Antimicrobial Management
7. Infection Control and Prevention Measures
8. Special Populations and Emerging Challenges

Learning Objectives

Upon completion of this course, students will be able to:

• Understand the historical development and clinical significance of MRSA as a major healthcare-associated and community-acquired pathogen
• Explain the microbiological characteristics of MRSA and the mechanisms underlying methicillin resistance
• Identify risk factors for MRSA acquisition and describe transmission dynamics in healthcare and community settings
• Recognize the diverse clinical presentations of MRSA infections ranging from superficial skin infections to life-threatening invasive disease
• Apply appropriate diagnostic testing methods and interpret laboratory results for MRSA identification
• Develop evidence-based treatment plans using current antimicrobial agents and adjunctive therapies
• Implement effective infection prevention and control strategies to reduce MRSA transmission
• Address unique considerations in managing MRSA infections in vulnerable populations including neonates, immunocompromised patients, and those with chronic conditions